GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sinocare Inc (SZSE:300298) » Definitions » Cyclically Adjusted Price-to-FCF

Sinocare (SZSE:300298) Cyclically Adjusted Price-to-FCF : 83.91 (As of Jun. 06, 2024)


View and export this data going back to 2012. Start your Free Trial

What is Sinocare Cyclically Adjusted Price-to-FCF?

As of today (2024-06-06), Sinocare's current share price is ¥26.85. Sinocare's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 was ¥0.32. Sinocare's Cyclically Adjusted Price-to-FCF for today is 83.91.

The historical rank and industry rank for Sinocare's Cyclically Adjusted Price-to-FCF or its related term are showing as below:

SZSE:300298' s Cyclically Adjusted Price-to-FCF Range Over the Past 10 Years
Min: 61.65   Med: 122.63   Max: 217.64
Current: 86.68

During the past years, Sinocare's highest Cyclically Adjusted Price-to-FCF was 217.64. The lowest was 61.65. And the median was 122.63.

SZSE:300298's Cyclically Adjusted Price-to-FCF is ranked worse than
81.01% of 237 companies
in the Medical Devices & Instruments industry
Industry Median: 43.19 vs SZSE:300298: 86.68

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Sinocare's adjusted free cash flow per share data for the three months ended in Mar. 2024 was ¥-0.213. Add all the adjusted free cash flow per share for the past 10 years together and divide 10 will get our Cyclically Adjusted FCF per Share, which is ¥0.32 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Sinocare Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Sinocare's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sinocare Cyclically Adjusted Price-to-FCF Chart

Sinocare Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 148.22 128.42 126.50 89.60

Sinocare Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 116.43 90.05 84.44 89.60 65.28

Competitive Comparison of Sinocare's Cyclically Adjusted Price-to-FCF

For the Medical Devices subindustry, Sinocare's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sinocare's Cyclically Adjusted Price-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Sinocare's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Sinocare's Cyclically Adjusted Price-to-FCF falls into.



Sinocare Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Sinocare's Cyclically Adjusted Price-to-FCF for today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/ Cyclically Adjusted FCF per Share
=26.85/0.32
=83.91

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sinocare's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Sinocare's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-0.213/115.2271*115.2271
=-0.213

Current CPI (Mar. 2024) = 115.2271.

Sinocare Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 0.022 98.200 0.026
201409 0.059 98.900 0.069
201412 0.153 99.000 0.178
201503 -0.057 99.900 -0.066
201506 0.075 99.500 0.087
201509 0.050 100.500 0.057
201512 0.068 100.600 0.078
201603 0.123 102.200 0.139
201606 0.104 101.400 0.118
201609 0.183 102.400 0.206
201612 -0.048 102.600 -0.054
201703 0.135 103.200 0.151
201706 0.135 103.100 0.151
201709 0.124 104.100 0.137
201712 -0.081 104.500 -0.089
201803 -0.042 105.300 -0.046
201806 -0.051 104.900 -0.056
201809 0.149 106.600 0.161
201812 0.062 106.500 0.067
201903 -0.302 107.700 -0.323
201906 0.181 107.700 0.194
201909 -0.011 109.800 -0.012
201912 0.314 111.200 0.325
202003 0.003 112.300 0.003
202006 0.130 110.400 0.136
202009 0.130 111.700 0.134
202012 0.148 111.500 0.153
202103 -0.351 112.662 -0.359
202106 0.042 111.769 0.043
202109 0.067 112.215 0.069
202112 0.388 113.108 0.395
202203 -0.187 114.335 -0.188
202206 0.198 114.558 0.199
202209 0.475 115.339 0.475
202212 0.165 115.116 0.165
202303 -0.059 115.116 -0.059
202306 0.263 114.558 0.265
202309 0.064 115.339 0.064
202312 0.430 114.781 0.432
202403 -0.213 115.227 -0.213

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Sinocare  (SZSE:300298) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Sinocare Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Sinocare's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Sinocare (SZSE:300298) Business Description

Traded in Other Exchanges
N/A
Address
No.265 Guyuan Road, Hi-tech Zone, Hunan Province, Changsha, CHN, 410205
Sinocare Inc operates in the healthcare industry. It is engaged in the development, manufacturing, and marketing of diagnosis testing products for people with chronic diseases and healthcare professionals. Its product range covers household blood glucose meter, medical blood glucose meter, urinary microalbumin test strip and blood lipid uric acid products. In addition, the company also provides diabetes management information systems.
Executives
Li Shao Bo Directors, executives
Che Hong Jing Director
Wang Shi Min Executives
Huang An Guo Directors, executives
Directors, executives
Pan Shu Guang Securities Affairs Representative
Zhou Qing Hua Supervisors
Ning Gui Chun Supervisors
Wang Rui Securities Affairs Representative
Chen Ji Dong Supervisors
Che Hong Li Directors, executives
Zhang Fan Director

Sinocare (SZSE:300298) Headlines

No Headlines